N/A
18 Years
90 Years
18 Years
90 Years
Open (Enrolling)
Both
Lung Cancer With Mediastinal Lymph Node Involvement
Both
Lung Cancer With Mediastinal Lymph Node Involvement
Trial Information
Inclusion Criteria:
- clinical diagnosis of lung cancer
- enlarged mediastinal or hilar lymph nodes (>10 mm)
Exclusion Criteria:
- clinical condition which excludes general anesthesia
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Diagnostic Performance of SHOX2
Outcome Description:
Diagnostic performance of SHOX2 methylation Level as biomarker for lung cancer compared to histologic evaluation of EBUS-TBNA specimen alone.
Outcome Time Frame:
one Year
Safety Issue:
No
Authority:
Germany: Ethics Commission
Study ID:
RLK-Epi-1
NCT ID:
NCT01653002
Start Date:
February 2012
Completion Date:
Related Keywords:
- Lung Cancer With Mediastinal Lymph Node Involvement
- Lung cancer
- EBUS-TBNA
- Epigenetics
- shox2 protein, human
- Lung Neoplasms
Name | Location |
|---|
